Scroll to top
Tag: neuromodulation

Clinical Trial to Test Wearable Device as Treatment for Chronic Pain, Opioid Withdrawal

Article Excerpt: A multi-year clinical trial at the University of Texas Medical Branch (UTMB) and Medical University of South Carolina (MUSC) will examine the use of a wearable device thought to stimulate nerves near the ear to change signals in the brain as a treatment for chronic pain and opioid tapering. The trial, known as tANdem, is being funded by an $8.8 million grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke, and is designed to provide an understanding of the mechanistic, neurophysiological and antinociceptive effects of transcutaneous auricular neurostimulation (tAN), which has been shown to reduce pain and the symptoms of withdrawal.

Full Article:

Article Source: Investors Observer


FDA Grants Breakthrough Designation to Magnus’ Neurostimulation Technology

Article Excerpt: The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Magnus Medical’s neurostimulation technology for the treatment of major depressive disorder (MDD). Developed based on the SAINT technology, the new, non-invasive Magnus System acts rapidly and is designed to treat MDD in people who have not sufficiently recovered after receiving antidepressant medication or other therapies… According to an investigational randomised controlled trial (RCT) published on the American Journal of Psychiatry website, the individually targeted neurostimulation technology relieved severe depression in 79% of people who received active treatment.

Full Article:

Article Source: Medical Device Network


Brain Implants Could Fight Opioid Addiction

Article Excerpt: As pharmaceutical companies begin taking ownership of the opioid epidemic in America, those affected by the issue are working to break their addiction. A recent NBC News article discussed a new strategy designed to help in their effort. The concept is in clinical trials at West Virginia’s University’s Rockefeller Neuroscience Institute, and it involves deep brain stimulation to kill cravings.

Full Article:

Article Source: Healthcare Packaging


Houston Med-Tech Companies Partner on Wearable Device for Opioid Withdrawal

Article Excerpt: Houston-based Spark Biomedical has created a revolutionary wearable device that provides unprecedented levels of opioid withdrawal relief. The device known as the Sparrow Therapy System is worn over the ear for five to seven days and sends mild electrical signals to trigger cranial nerves that sit near the skin’s surface. Once activated, the nerves release endorphins that the body has stopped producing on its own during opioid use. The endorphins satisfy the opioid receptors and in turn reduce or prevent the intense symptoms that often come along with opioid withdrawal. According to Spark BioMed CEO Daniel Powell, the technology also helps patients better control their “flight or fight mechanisms,” allowing them to make clearer, more logical decisions as they come off of the drug.

Full Article:

Article Source: Innovation Map


First-Of-Its-Kind Brain Chip to Treat Mental Disorders Being Developed at the U of M

Article Excerpt: A first-of-its-kind brain chip that would be used to treat severe mental disorders is being developed in the Twin Cities. A team at the University of Minnesota Medical School recently received a $6.6 million grant from the National Institute of Mental Health to create, build and test a brain implant. “It’s going to be a chip, like a millimeter on each side, maybe even less, but it is going to be the heart of this new technology,” said Dr. Alik Widge, an assistant professor in the medical school’s psychiatry department, who is the principal investigator on the project…Dr. Widge said people with severe mental health disorders often have brain waves that are out of sync. He believes the key to fixing the problem is getting the circuit reconnected.

Full Article:

Article Source: KSTP-TV


BrainsWay Receives FDA Clearance for Smoking Addiction in Adults

Article Excerpt: This FDA clearance represents a significant milestone for BrainsWay and our Deep TMS platform technology,” stated Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay. “Smoking is one of the leading causes of death in the U.S. and also leads to other serious conditions, such as lung cancer and heart disease. While other therapies are currently available, a substantial medical need continues to exist for treatments that can increase the continuous quit rate among smokers. Based on the compelling data from our large, randomized pivotal study of 262 subjects, we are confident that our Deep TMS technology can play an important role in treating cigarette smokers who seek to quit.

Full Article:

Article Source: BioSpace


Chip Implanted in Brain May Help Curb Opioid Addiction

Article Excerpt: An Independent news article tells of a man who has undergone surgery to help him with addiction. Gerod Buckhalter has faced drug overdoses and has a chip inserted in his brain. Buckhalter’s 10-year battle with opioids and benzodiazepines has proven a difficult experience for him, but the surgical implantation of a Deep Brain Simulation (or DBS) may be a step in the right direction.

Full Article:

Article Source: Addiction Center


‘Cyborg’ Technology Aims to Reduce the Opioid Epidemic One Chip at a Time

Article Excerpt: Tech these days is often accused of encouraging forms of addiction, but emerging “cyborg” technology may offer an answer for treating the opioid epidemic. Embedding microchips in the brains of addicts could help to, essentially, rewire them.

Full Article:

Article Source: USA Today